Relx (NYSE:RELX - Get Free Report) was downgraded by StockNews.com from a "buy" rating to a "hold" rating in a research report issued on Tuesday.
Separately, Redburn Atlantic initiated coverage on shares of Relx in a research report on Wednesday, January 8th. They issued a "buy" rating for the company.
Get Our Latest Stock Analysis on Relx
Relx Stock Up 1.2 %
RELX stock traded up $0.57 during midday trading on Tuesday, hitting $47.81. 292,923 shares of the company's stock were exchanged, compared to its average volume of 598,944. The company has a current ratio of 0.52, a quick ratio of 0.47 and a debt-to-equity ratio of 1.46. The stock has a market capitalization of $88.86 billion, a price-to-earnings ratio of 25.71, a price-to-earnings-growth ratio of 2.73 and a beta of 0.90. Relx has a 12-month low of $40.25 and a 12-month high of $51.99. The firm has a 50 day moving average price of $48.57 and a 200-day moving average price of $47.52.
Hedge Funds Weigh In On Relx
Large investors have recently bought and sold shares of the business. CENTRAL TRUST Co boosted its position in Relx by 1,290.2% during the 4th quarter. CENTRAL TRUST Co now owns 570 shares of the technology company's stock worth $26,000 after acquiring an additional 529 shares during the last quarter. Versant Capital Management Inc acquired a new stake in Relx during the 4th quarter worth approximately $31,000. Transce3nd LLC acquired a new stake in shares of Relx in the fourth quarter valued at approximately $40,000. Sierra Ocean LLC acquired a new position in Relx in the fourth quarter valued at about $43,000. Finally, Brown Brothers Harriman & Co. raised its position in Relx by 218.5% during the fourth quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company's stock valued at $44,000 after purchasing an additional 662 shares in the last quarter. 15.02% of the stock is currently owned by institutional investors and hedge funds.
About Relx
(
Get Free Report)
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Read More
Before you consider Relx, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.
While Relx currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
